Rule 30(b)(6) Changes One Year Later: Eliminating Deficient Subject Lists and Securing Better Prepared Witnesses

Mr. Regan is a partner in the Newark office of Lewis Brisbois and a member of the Products Liability Practice. He focuses his practice on the management and defense of large dockets of cases filed in multiple jurisdictions. Mr. Regan has advised on and provided clients with legal process mapping and systems to manage claims, implement internal response planning, and establish data collection protocols. A highly skilled commercial litigator with substantial first chair trial experience, he frequently represents corporate entities, from multinational Fortune 500 companies to closely held companies and individuals, against claims of serious and catastrophic injury that allegedly result from product liability or negligence and against claims of breach of warranty.

Ms. Schultz is an attorney in Ford’s Office of the General Counsel in the Litigation and Regulatory Group. She joined Ford after a career as a trial lawyer and partner at the Dykema firm in Bloomfield Hills, Michigan. Ms. Schultz has tried numerous cases to verdict and has presented and defended numerous witnesses as Rule 30(b)(6) witnesses. She also has extensive expertise on discovery matters. Ms. Schultz attended the University of Michigan-Ann Arbor and graduated in 1997. She attended the Wayne State University law School achieving her law degree in 2001. 

Ms. Grossman is a partner in the Philadelphia office of Lewis Brisbois and a vice-chair of the Life Sciences Practice. She is a trial attorney representing companies in general liability, products liability and complex litigation matters. Having started her career in the biomedical field, Ms. Grossman now focuses her practice on representing various medical device and pharmaceutical companies in products liability matters relating to life sciences and biotechnology. She represents medical device companies in claims arising out of alleged malfunctions of surgical equipment, instruments, and implants; defending pharmaceutical companies in actions arising out of personal injury claims involving prescription medicines or over-the-counter (OTC) drugs; defending companies in relation to claims involving clinical trials; and serving as defense counsel in numerous mass-tort litigations both locally and nationwide. Ms. Grossman has also defended several compounding pharmacies in wrongful death/medical malpractice matters. She is experienced in all stages of litigation, including the coordination of discovery, trial preparation, depositions, court appearances, fact investigation, and the drafting of pleadings, motions, and briefs in state and federal jurisdictions.